Merck To Ship Hepatitis C Drug Victrelis To Pharmacies Within A Week
FDA approves boceprevir, the first protease inhibitor for hepatitis C, without overly proscriptive labeling.
FDA approves boceprevir, the first protease inhibitor for hepatitis C, without overly proscriptive labeling.